Connect
MJA
MJA

Management of pregabalin and gabapentin prescribing and use in NSW prisons

Gary Nicholls, Peter Samios and Stephen Hampton
Med J Aust 2019; 211 (10) || doi: 10.5694/mja2.50398
Published online: 18 November 2019

To the Editor: The editorial by Murnion and Conigrave1 and the article by Crossin and colleagues2 on the dangers of misuse of pregabalin are a timely warning to all prescribers. The black market utility (based on testimonies) and frequent misuse of pregabalin is well known both academically and to prescribers in prison environments.3,4

The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.


  • 1 Justice Health and Forensic Mental Health Network, Sydney, NSW
  • 2 UNSW Sydney, Sydney, NSW



Acknowledgements: 

Primary care clinical staff at Justice Health and Forensic Mental Health Network.

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.